Brief: JCR Pharmaceuticals announces business and capital alliance with Medipal Holdings
Sept 21(Reuters) - JCR Pharmaceuticals Co Ltd 4552.T
* Says it signed a business and capital alliance with
Medipal Holdings Corp 7459.T
* Says the two companies will set up a joint venture in U.S.
* Says Medipal Holdings will acquire 22 percent stake in the
company for 21.18 billion yen, and will increase stake in the
company to 22.5 percent from 0.5 percent, with acquisition date
in late October
Source text in Japanese:https://goo.gl/YYQCFk
Further company coverage: 4552.T 7459.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows